Dexcom G6 Observational Study

Completed · Not applicable

Conditions studied: Diabetes

In brief

This is an exploratory prospective study primary aiming to evaluate differences between Point-of-care (POC) testing (standard of care) and Dexcom G6 CGM (Continues Glucose Monitoring sensor system) in 1) glycemic control measured by mean daily blood glucose and 2) identifying hypoglycemic and hyperglycemic events - in patients with type 1 and type 2 diabetes treated with basal bolus insulin regimen.

Key facts

Study ID

NCT03832907

Run by

Emory University

People needed

101

Starts

2019-02-21

Expected to finish

2020-03-31

Last updated by the study team

2021-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years admitted to a general medicine or surgical service.
• Known history of T1D or T2D receiving insulin therapy
• Subjects must have a randomization BG between 140 mg and 400 mg/dL without laboratory evidence of diabetic ketoacidosis (bicarbonate < 18 mEq/L, pH < 7.30, or positive serum or urinary ketones).
• Patients with expected hospital length-of-stay of 3 or more days

You may not qualify if…

• Patients with acute illness admitted to the ICU or expected to require admission to the ICU.
• Patients expected to require MRI procedures during hospitalization.
• Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
• Female subjects who are pregnant or breast-feeding at time of enrollment into the study.

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.